Integra Lifesciences wants to sell its Spine businesses – SeaSpine & Theken Spine

By

Integra Lifesciences Expresses Interest to Divest Spine Business (HealthPointCapital)
Last week, Glenn Coleman the CFO of Integra Lifesciences, expressed to analysts that the company is interested in exploring strategic alternatives for its Spine business.
Integra's management team believes that Integra's Spine unit would need a significant investment in order to compete in the market with Medtronic, Johnson & Johnson, Stryker and others, an investment that the company is not prepared to make. On the 2Q:14 earnings call, Integra's CEO, Peter Arduini, conveyed that for Spine, the company wo...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.